Real-World and Regulatory Perspectives of Artificial Intelligence in Cardiovascular Imaging
Recent progress in digital health data recording, advances in computing power, and methodological approaches that extract information from data as artificial intelligence are expected to have a disruptive impact on technology in medicine. One of the potential benefits is the ability to extract new a...
Main Author: | Ernst Wellnhofer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.890809/full |
Similar Items
-
Trends in the Approval and Quality Management of Artificial Intelligence Medical Devices in the Republic of Korea
by: Kyoungtaek Lim, et al.
Published: (2022-01-01) -
Supervision System of AI-based Software as a Medical Device
by: Zhang Jiannan, et al.
Published: (2022-02-01) -
A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?
by: Christian Baumgartner, et al.
Published: (2023-08-01) -
FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate
by: Anthony Watson, et al.
Published: (2023-04-01) -
Regulating Artificial Intelligence and Machine Learning-Enabled Medical Devices in Europe and the United Kingdom
by: Phoebe Li, et al.
Published: (2023-11-01)